Patent · US Active

Amlodipine formulations

US10799453B2 · kind B2 · utility

7Cited by
24References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2019
Grant dateOct 13, 2020
Priority date—
Expiry dateApr 11, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.